Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Nonalcoholic fatty liver disease in CLOCK mutant mice
Xiaoyue Pan, … , Joyce Queiroz, M. Mahmood Hussain
Xiaoyue Pan, … , Joyce Queiroz, M. Mahmood Hussain
Published May 12, 2020
Citation Information: J Clin Invest. 2020;130(8):4282-4300. https://doi.org/10.1172/JCI132765.
View: Text | PDF
Research Article Hepatology Metabolism

Nonalcoholic fatty liver disease in CLOCK mutant mice

  • Text
  • PDF
Abstract

Nonalcoholic fatty liver disease (NAFLD) is becoming a major health issue as obesity increases around the world. We studied the effect of a circadian locomotor output cycles kaput (CLOCK) mutant (ClkΔ19/Δ19) protein on hepatic lipid metabolism in C57BL/6 Clkwt/wt and apolipoprotein E–deficient (Apoe−/−) mice. Both ClkΔ19/Δ19 and ClkΔ19/Δ19 Apoe−/− mice developed a full spectrum of liver diseases (steatosis, steatohepatitis, cirrhosis, and hepatocellular carcinoma) recognized in human NAFLD when challenged with a Western diet, lipopolysaccharide, or CoCl2. We identified induction of CD36 and hypoxia-inducible factor 1α (HIF1α) proteins as contributing factors for NAFLD. Mechanistic studies showed that WT CLOCK protein interacted with the E-box enhancer elements in the promoters of the proline hydroxylase domain (PHD) proteins to increase expression. In ClkΔ19/Δ19 mice, PHD levels were low, and HIF1α protein levels were increased. When its levels were high, HIF1α interacted with the Cd36 promoter to augment expression and enhance fatty acid uptake. Thus, these studies establish a regulatory link among circadian rhythms, hypoxia response, fatty acid uptake, and NAFLD. The mouse models described here may be useful for further mechanistic studies in the progression of liver diseases and in the discovery of drugs for the treatment of these disorders.

Authors

Xiaoyue Pan, Joyce Queiroz, M. Mahmood Hussain

×

Figure 10

CoCl2 induces HIF1α in macrophages in ClkΔ19/Δ19 Apoe–/– mice.

Options: View larger image (or click on image) Download as PowerPoint
CoCl2 induces HIF1α in macrophages in ClkΔ19/Δ19 Apoe–/– mice.
Animals w...
Animals were treated with CoCl2 as described in Figure 9 and used to collect tissues (n = 6 per group), to study hepatic [3H]OA uptake or [14C]OA oxidation (n = 6 per group), or for isolation of Kupffer cells (n = 6 per group). (A and B) Triglyceride levels decreased (A) but TBARS increased (B) in livers of CoCl2-injected ClkΔ19/Δ19 Apoe−/− mice. (C) Plasma ALT levels increased in CoCl2-injected ClkΔ19/Δ19 Apoe−/− mice. In contrast, plasma β-HB concentrations decreased in CoCl2-injected ClkΔ19/Δ19 Apoe−/− mice. (D) Livers from CoCl2-injected ClkΔ19/Δ19 Apoe−/− mice assimilated less [3H]OA than controls. (E) Liver slices from CoCl2-injected ClkΔ19/Δ19 Apoe−/− mice were used to study fatty acid uptake and oxidation. (F) Expression of lipoprotein assembly and β-oxidation genes was reduced in CoCl2-injected ClkΔ19/Δ19 Apoe−/− mice. Mean ± SD; *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, multiple t tests. (G) Kupffer cells isolated from CoCl2-injected ClkΔ19/Δ19 Apoe−/− mice took up more DiI-labeled AcLDL (5 μg/mL). Kupffer cells were incubated with DiI-labeled AcLDL (5 μg/mL) for 4 hours. Cells were washed, lipids were extracted, and dye was measured at 485 nm. (H) Kupffer cells isolated from CoCl2-injected Clkwt/wt Apoe−/− and ClkΔ19/Δ19 Apoe−/− mice were incubated with DiI-AcLDL. Mean ± SD; ***P < 0.001, 2-way ANOVA, Šidák’s multiple-comparisons test. (I) mRNA levels of different genes in isolated Kupffer cells from CoCl2-injected mice. Mean ± SD; ***P < 0.001, ****P < 0.0001, multiple t tests. (J) ChIP assays were performed in Kupffer cells isolated from livers of indicated mice to study the binding of HIF1α to the Cd36 promoter. Data are representative of 2 experiments.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts